Precision therapy. Personalized care.
We are passionate about targeted cancer care expertly tailored to meet patients’ personalized needs. We carefully designed the Xoft® Axxent® Electronic Brachytherapy (eBx®) System® to empower physicians with full confidence to precisely and effectively treat cancer and enable patients to live healthy, high-quality lives.
iCAD’s Response to COVID-19
Read our response to COVID-19 and learn how our portfolio of solutions supporting cancer detection and therapy continue to offer significant benefits to clinicians, patients and the overall healthcare system.
The Impact of COVID-19 on Breast Cancer Surgery and Targeted Radiation Therapy
How are clinicians changing their approach to cancer treatment during the COVID-19 pandemic? Join us for a free virtual roundtable featuring leading breast cancer experts who will share best practices and discuss how targeted radiation therapy is emerging as a way to optimize workflow and minimize COVID-19 exposure to patients and clinicians, while preserving high-quality care.
Thursday, June 4, 2020 at 7:00 pm EDT | 4:00 pm PDT
From the Newsroom
February 11, 2020
First Brain Tumor Treated with Xoft IORT in the United States
Medical City Plano, a HCA Healthcare Facility, becomes first in Texas to offer intraoperative radiation therapy with the advanced Xoft System to enhance patient care.
Discover the growing body of favorable clinical data supporting the use of electronic brachytherapy (eBx) in patients meeting specific selection criteria.
Discover our Advanced, Multi-Platform System
©2019 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.